143 related articles for article (PubMed ID: 9660039)
1. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children.
Haliotis FA; Papanastasiou DA
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):320-5. PubMed ID: 9660039
[TBL] [Abstract][Full Text] [Related]
2. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
[No Abstract] [Full Text] [Related]
3. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
Bopche AV; Dwivedi R; Mishra R; Patel GS
Indian Pediatr; 2009 Oct; 46(10):883-5. PubMed ID: 19430060
[TBL] [Abstract][Full Text] [Related]
4. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
5. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
Jaber L; Rigler S; Taya A; Tebi F; Baloum M; Yaniv I; Haj Yehia M; Tamary H
J Pediatr Hematol Oncol; 2010 Nov; 32(8):585-8. PubMed ID: 20930652
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity.
Köpcke W; Sauerland MC
Arzneimittelforschung; 1995 Nov; 45(11):1211-6. PubMed ID: 8929242
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study.
Ortiz R; Toblli JE; Romero JD; Monterrosa B; Frer C; Macagno E; Breymann C
J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1347-52. PubMed ID: 21859366
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study.
Nappi C; Tommaselli GA; Morra I; Massaro M; Formisano C; Di Carlo C
Acta Obstet Gynecol Scand; 2009; 88(9):1031-5. PubMed ID: 19639462
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
Casparis D; Del Carlo P; Branconi F; Grossi A; Merante D; Gafforio L
Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381
[TBL] [Abstract][Full Text] [Related]
10. Iron protein succynilate in the treatment of iron deficiency: potential interaction with H2-receptor antagonists.
Bianchi FM; Cavassini GB; Leo P
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):209-17. PubMed ID: 8100220
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
Pinsk V; Levy J; Moser A; Yerushalmi B; Kapelushnik J
Isr Med Assoc J; 2008 May; 10(5):335-8. PubMed ID: 18605353
[TBL] [Abstract][Full Text] [Related]
12. [Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():21-3. PubMed ID: 12412350
[No Abstract] [Full Text] [Related]
13. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta BC
J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
[No Abstract] [Full Text] [Related]
14. Controlled, double-blind, multicenter clinical trial of iron protein succinylate in the treatment of iron deficiency in children.
Careddu P; Scotti A
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):157-69. PubMed ID: 8500917
[TBL] [Abstract][Full Text] [Related]
15. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
Sözmen EY; Kavakli K; Cetinkaya B; Akçay YD; Yilmaz D; Aydinok Y
Biol Trace Elem Res; 2003 Jul; 94(1):79-86. PubMed ID: 12907830
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of iron protein succinylate oral solution for preventing and treating anemia of prematurity].
Xing Y; Tong XM
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1059-63. PubMed ID: 24342196
[TBL] [Abstract][Full Text] [Related]
17. Iron Bisglycinate Chelate and Polymaltose Iron for the Treatment of Iron Deficiency Anemia: A Pilot Randomized Trial.
Name JJ; Vasconcelos AR; Valzachi Rocha Maluf MC
Curr Pediatr Rev; 2018; 14(4):261-268. PubMed ID: 30280670
[TBL] [Abstract][Full Text] [Related]
18. Effect of twice weekly versus daily iron treatment in Turkish children with iron deficiency anemia.
Tavil B; Sipahi T; Gökçe H; Akar N
Pediatr Hematol Oncol; 2003 Jun; 20(4):319-26. PubMed ID: 12746164
[TBL] [Abstract][Full Text] [Related]
19. Are ferric compounds useful in treatment of iron deficiency anemia?
Arvas A; Gür E
Turk J Pediatr; 2000; 42(4):352-3. PubMed ID: 11196760
[TBL] [Abstract][Full Text] [Related]
20. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis.
Toblli JE; Brignoli R
Arzneimittelforschung; 2007; 57(6A):431-8. PubMed ID: 17691593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
